Lmcg Investments LLC Sells 4,100 Shares of Agilent Technologies, Inc. (NYSE:A)

Lmcg Investments LLC lowered its position in shares of Agilent Technologies, Inc. (NYSE:A - Free Report) by 5.1% in the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 75,528 shares of the medical research company's stock after selling 4,100 shares during the period. Lmcg Investments LLC's holdings in Agilent Technologies were worth $8,835,000 at the end of the most recent reporting period.

A number of other large investors have also added to or reduced their stakes in A. Naples Global Advisors LLC boosted its holdings in Agilent Technologies by 13.1% in the first quarter. Naples Global Advisors LLC now owns 17,900 shares of the medical research company's stock valued at $2,094,000 after acquiring an additional 2,080 shares in the last quarter. Whipplewood Advisors LLC lifted its holdings in Agilent Technologies by 286.2% in the first quarter. Whipplewood Advisors LLC now owns 251 shares of the medical research company's stock worth $29,000 after buying an additional 186 shares during the period. Merit Financial Group LLC boosted its position in Agilent Technologies by 56.3% during the 1st quarter. Merit Financial Group LLC now owns 4,348 shares of the medical research company's stock valued at $509,000 after acquiring an additional 1,567 shares in the last quarter. Vantage Wealth grew its holdings in shares of Agilent Technologies by 20.9% during the 1st quarter. Vantage Wealth now owns 132,480 shares of the medical research company's stock worth $15,498,000 after acquiring an additional 22,890 shares during the period. Finally, NBC Securities Inc. raised its position in shares of Agilent Technologies by 113,700.0% in the 1st quarter. NBC Securities Inc. now owns 2,276 shares of the medical research company's stock worth $266,000 after acquiring an additional 2,274 shares in the last quarter.

Insiders Place Their Bets

In other news, VP Rodney Gonsalves sold 1,908 shares of the business's stock in a transaction on Monday, March 17th. The shares were sold at an average price of $121.98, for a total value of $232,737.84. Following the transaction, the vice president now owns 21,786 shares of the company's stock, valued at approximately $2,657,456.28. The trade was a 8.05% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Daniel K. Podolsky sold 1,819 shares of the company's stock in a transaction on Monday, March 31st. The stock was sold at an average price of $116.46, for a total transaction of $211,840.74. Following the transaction, the director now owns 35,737 shares of the company's stock, valued at approximately $4,161,931.02. This represents a 4.84% decrease in their position. The disclosure for this sale can be found here.

Wall Street Analyst Weigh In

Several equities analysts have commented on the company. TD Cowen raised their price objective on Agilent Technologies to $150.00 and gave the company a "buy" rating in a research report on Thursday, May 29th. UBS Group dropped their price objective on shares of Agilent Technologies from $150.00 to $130.00 and set a "neutral" rating on the stock in a research note on Thursday, May 29th. Leerink Partners raised their target price on shares of Agilent Technologies to $135.00 and gave the company a "buy" rating in a research note on Friday, May 30th. Robert W. Baird dropped their price target on Agilent Technologies from $159.00 to $140.00 and set an "outperform" rating on the stock in a research report on Thursday, May 22nd. Finally, JPMorgan Chase & Co. cut their price target on Agilent Technologies from $160.00 to $155.00 and set an "overweight" rating on the stock in a research note on Thursday, May 29th. Seven equities research analysts have rated the stock with a hold rating and eight have issued a buy rating to the company's stock. Based on data from MarketBeat, the company has an average rating of "Moderate Buy" and an average price target of $140.15.

Agilent Technologies Stock Performance

A traded up $1.96 during mid-day trading on Friday, reaching $115.90. 1,556,432 shares of the company traded hands, compared to its average volume of 1,916,763. The company's fifty day moving average price is $108.05 and its 200-day moving average price is $126.01. The stock has a market capitalization of $32.92 billion, a P/E ratio of 28.62, a P/E/G ratio of 3.49 and a beta of 1.23. The company has a quick ratio of 1.60, a current ratio of 2.09 and a debt-to-equity ratio of 0.55. Agilent Technologies, Inc. has a 52-week low of $96.43 and a 52-week high of $153.84.

Agilent Technologies (NYSE:A - Get Free Report) last issued its quarterly earnings data on Wednesday, May 28th. The medical research company reported $1.31 EPS for the quarter, topping the consensus estimate of $1.26 by $0.05. The company had revenue of $1.67 billion during the quarter, compared to analyst estimates of $1.63 billion. Agilent Technologies had a return on equity of 25.92% and a net margin of 17.59%. Agilent Technologies's revenue was up 6.0% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.22 earnings per share. On average, sell-side analysts expect that Agilent Technologies, Inc. will post 5.58 EPS for the current year.

Agilent Technologies Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, July 23rd. Shareholders of record on Tuesday, July 1st will be issued a dividend of $0.248 per share. The ex-dividend date of this dividend is Tuesday, July 1st. This represents a $0.99 dividend on an annualized basis and a yield of 0.86%. Agilent Technologies's dividend payout ratio is currently 24.44%.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.